Boron has gradually resurfaced for its medical importance after several studies proved its nutrient value and medicinal properties. Boron-containing compounds were used as antiseptics for decades, thus gaining significance for external usage. However, recent studies demonstrated that boron compounds could also be used as internal agents (Baker et al., 2009). The recently FDA-approved drug Bortezomib cemented the metal's biological activity and nullified its toxicity concerns (Liu, Zhao, Jiang, Li, & Zhang, 2021). Boron is a micronutrient present in the animal body with an indispensable function, playing a vital role in various processes, including the folding of macrolides inside the human body, maintenance of Vitamin D levels, and improving bone health as well as combating the cancer risk in mammalian cells. Moreover, it was found to be appropriately stable in the physiological pH, helping the element to attain immense pharmaceutical applicability. Boron has served as a therapeutic agent for various diseases, including cancer, HIV, rheumatoid arthritis, bacterial infections, and fungal infections. Therefore, boron attained huge momentum resulting in the design and development of a new range of medicinal compounds (Chatterjee, Tripathi, & Bandyopadhyay, 2021).